Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.

Gerlies Treiber; Barbara Prietl; Elke Fröhlich-Reiterer; Evelyne Lechner; Anja Ribitsch; Maria Fritsch; Birgit Rami-Merhar; Claudia Steigleder-Schweiger; Winfried Graninger; Martin Borkenstein; Thomas R Pieber

doi:10.1016/j.clim.2015.08.002

Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.

Gerlies Treiber, Barbara Prietl, Elke Fröhlich-Reiterer, Evelyne Lechner, Anja Ribitsch, Maria Fritsch, Birgit Rami-Merhar, Claudia Steigleder-Schweiger, Winfried Graninger, Martin Borkenstein, Thomas R Pieber

Department of Pediatrics

Research output: Contribution to journal › Original Article › peer-review

70 Citations (Web of Science)

Original language	English
Pages (from-to)	217-224
Journal	CLINICAL IMMUNOLOGY
Volume	161
Issue number	2
DOIs	https://doi.org/10.1016/j.clim.2015.08.002
Publication status	Published - 2015

Keywords

BETA-CELL
VITAMIN-D
NOD MICE
1-ALPHA,25-DIHYDROXYVITAMIN D-3
1,25-DIHYDROXYVITAMIN D-3
AUTOIMMUNE-DISEASES
DENDRITIC CELLS
IMMUNE FUNCTION
THERAPY
APOPTOSIS

Access to Document

10.1016/j.clim.2015.08.002

Cite this

Treiber, G., Prietl, B., Fröhlich-Reiterer, E., Lechner, E., Ribitsch, A., Fritsch, M., Rami-Merhar, B., Steigleder-Schweiger, C., Graninger, W., Borkenstein, M., & Pieber, T. R. (2015). Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial. CLINICAL IMMUNOLOGY , 161(2), 217-224. https://doi.org/10.1016/j.clim.2015.08.002

Treiber, Gerlies ; Prietl, Barbara ; Fröhlich-Reiterer, Elke et al. / Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial. In: CLINICAL IMMUNOLOGY 2015 ; Vol. 161, No. 2. pp. 217-224.

@article{6aca121193de401c805a313cfd772f9d,

title = "Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.",

keywords = "BETA-CELL, VITAMIN-D, NOD MICE, 1-ALPHA,25-DIHYDROXYVITAMIN D-3, 1,25-DIHYDROXYVITAMIN D-3, AUTOIMMUNE-DISEASES, DENDRITIC CELLS, IMMUNE FUNCTION, THERAPY, APOPTOSIS",

author = "Gerlies Treiber and Barbara Prietl and Elke Fr{\"o}hlich-Reiterer and Evelyne Lechner and Anja Ribitsch and Maria Fritsch and Birgit Rami-Merhar and Claudia Steigleder-Schweiger and Winfried Graninger and Martin Borkenstein and Pieber, {Thomas R}",

note = "Steigleder-Schweiger: Department of Paediatrics, Paracelsus Medical University Salzburg, M{\"u}llner Hauptstra{\ss}e 48, 5020 Salzburg, Austria",

year = "2015",

doi = "10.1016/j.clim.2015.08.002",

language = "English",

volume = "161",

pages = "217--224",

journal = "CLINICAL IMMUNOLOGY ",

issn = "1521-6616",

number = "2",

}

Treiber, G, Prietl, B, Fröhlich-Reiterer, E, Lechner, E, Ribitsch, A, Fritsch, M, Rami-Merhar, B, Steigleder-Schweiger, C, Graninger, W, Borkenstein, M & Pieber, TR 2015, 'Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.', CLINICAL IMMUNOLOGY , vol. 161, no. 2, pp. 217-224. https://doi.org/10.1016/j.clim.2015.08.002

Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial. / Treiber, Gerlies; Prietl, Barbara; Fröhlich-Reiterer, Elke et al.
In: CLINICAL IMMUNOLOGY , Vol. 161, No. 2, 2015, p. 217-224.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.

AU - Treiber, Gerlies

AU - Prietl, Barbara

AU - Fröhlich-Reiterer, Elke

AU - Lechner, Evelyne

AU - Ribitsch, Anja

AU - Fritsch, Maria

AU - Rami-Merhar, Birgit

AU - Steigleder-Schweiger, Claudia

AU - Graninger, Winfried

AU - Borkenstein, Martin

AU - Pieber, Thomas R

N1 - Steigleder-Schweiger: Department of Paediatrics, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria

PY - 2015

Y1 - 2015

KW - BETA-CELL

KW - VITAMIN-D

KW - NOD MICE

KW - 1-ALPHA,25-DIHYDROXYVITAMIN D-3

KW - 1,25-DIHYDROXYVITAMIN D-3

KW - AUTOIMMUNE-DISEASES

KW - DENDRITIC CELLS

KW - IMMUNE FUNCTION

KW - THERAPY

KW - APOPTOSIS

U2 - 10.1016/j.clim.2015.08.002

DO - 10.1016/j.clim.2015.08.002

M3 - Original Article

C2 - 26277548

SN - 1521-6616

VL - 161

SP - 217

EP - 224

JO - CLINICAL IMMUNOLOGY

JF - CLINICAL IMMUNOLOGY

IS - 2

ER -

Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial. CLINICAL IMMUNOLOGY . 2015;161(2):217-224. doi: 10.1016/j.clim.2015.08.002